FAM130A1 Inhibitors
Chemical inhibitors of FAM130A1 can directly impact its activity by altering the phosphorylation status and signaling pathways that control its function. Staurosporine, a potent kinase inhibitor, can inhibit a wide array of protein kinases that are responsible for the phosphorylation of many proteins, including FAM130A1. By preventing these kinases from activating, Staurosporine ensures that FAM130A1 remains in a dephosphorylated state, which is often associated with reduced functional activity. Similarly, Bisindolylmaleimide I targets Protein Kinase C (PKC), a kinase that can phosphorylate FAM130A1. By specifically inhibiting PKC, Bisindolylmaleimide I can decrease the phosphorylation level of FAM130A1, potentially leading to a reduction in its activity. Other inhibitors, such as LY294002 and Wortmannin, target the PI3K pathway, a critical signaling pathway for numerous cellular processes. These inhibitors can disrupt the PI3K/Akt pathway, which can have downstream effects on the activity of FAM130A1.
In addition to these, U0126 and PD98059 are both inhibitors of MEK, an upstream kinase in the MAPK/ERK pathway. Inhibition of MEK by these chemicals can prevent the activation of ERK, a kinase that may be necessary for the proper function of FAM130A1. SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively, both of which are important in the MAP kinase pathway. By inhibiting these kinases, both chemicals can prevent the phosphorylation of substrates involved in stress response and other signaling pathways, which could include FAM130A1. Rapamycin acts on mTOR, a component of the PI3K/AKT/mTOR pathway, and by inhibiting mTOR, it can influence the function of FAM130A1, as mTOR is involved in cell growth and protein synthesis. LFM-A13 selectively inhibits Bruton's tyrosine kinase (Btk), which is part of the B-cell receptor signaling pathway. The inhibition of Btk can affect downstream signaling pathways, which could influence FAM130A1 activity. Lastly, Gö 6983 and PP2 inhibit a broader range of PKC isoforms and Src family kinases, respectively. Through their broad-spectrum inhibition, they can disrupt various signaling pathways that regulate the activity of proteins like FAM130A1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. FAM130A1 is a protein that can be influenced by phosphorylation status. Staurosporine inhibits many kinases that could phosphorylate FAM130A1, thereby inhibiting its activation and functional state. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits Protein Kinase C (PKC). As PKC can phosphorylate a wide range of target proteins, inhibition of PKC can lead to a decrease in the phosphorylation and activity of FAM130A1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K is part of a pathway that regulates various cellular processes, including growth and proliferation. Inhibiting PI3K can disrupt the signaling cascade, potentially inhibiting the activity of FAM130A1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is upstream of ERK in the MAPK/ERK pathway. By inhibiting MEK, U0126 can prevent ERK activation, which may be necessary for the proper function of FAM130A1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. p38 MAP kinase is involved in cellular stress responses, and its inhibition can disrupt downstream signaling that may be crucial for the functional activity of FAM130A1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a covalent inhibitor of PI3K. Similar to LY294002, by inhibiting PI3K activity, wortmannin can disrupt the PI3K/Akt pathway, which can lead to the inhibition of FAM130A1 activity as this pathway influences many cellular functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits mTOR, which is part of the PI3K/AKT/mTOR pathway. mTOR is involved in cell growth and protein synthesis, and its inhibition can lead to reduced activity of downstream proteins, potentially including FAM130A1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAP kinase pathway. By inhibiting JNK, SP600125 can prevent the phosphorylation of proteins regulated by this pathway, possibly reducing the functional activity of FAM130A1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor, which by inhibiting MEK, can prevent the activation of ERK. As ERK is involved in a wide range of cellular functions, its inhibition can lead to a decrease in the activity of downstream proteins such as FAM130A1. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 is a selective inhibitor of Bruton's tyrosine kinase (Btk). Btk is a part of the B-cell receptor signaling pathway. Its inhibition can affect downstream signaling pathways, potentially leading to the functional inhibition of FAM130A1. | ||||||